Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia

Metabolism: Clinical and Experimental

Volumn 48, Issue 1, 1999, Pages 60-67

  Saïdi, Youssef ^a   Sich, Didier ^a   Camproux, Anne ^a   Egloff, Monique ^a   Federspiel, Marie Christine ^a   Gautier, Valérie ^a   Raisonnier, Alain ^a   Turpin, Gérard ^a   Beucler, Isabel ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERLIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032946893     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(99)90011-2     Document Type: Article

References (44)

1. Goldstein JL, Brown MS: The low-density lipoprotein pathway and its relation to atherosclerosis. Annu Rev Biochem 46:897-930, 1977
2. Kissebah AH, Alfarsi S, Adamo PW: Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein B kinetics in man: Normolipidemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Metabolism 30:856-868, 1981
3. Brunzell JD, Albers JJ, Chait A, et al: Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 24:147-155, 1983
4. Austin ME: Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11:2-14, 1991
5. National Institutes of Health Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Cardiovascular Heart Disease. JAMA 269:505-510, 1993
6. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J Cardiovasc Risk 3:213-219, 1996
7. Patsch JR, Karlin JB, Scott LW, et al: Inverse relationship between blood levels of high density lipoprotein and magnitude of postprandial lipemia. Proc Natl Acad Sci USA 80:1449-1453, 1983
8. Hopkins GJ, Barter PJ: Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins. J Lipid Res 27:1265-1273, 1986
9. Patsch JR, Miesenböck G, Hopferwieser T, et al: Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state. Arterioscler Thromb 12:1336-1345, 1992
10. Delalla OF, Elliot HA, Gofman JW: Ultracentrifugal studies of high density lipoproteins in clinically healthy adults. Am J Physiol 179:333-337, 1954
11. Blanche PJ, Gong EL, Forte TM, et al: Characterization of human high density lipoproteins by gradient gel electrophoresis. Biochim Biophys Acta 665:408-419, 1981
12. Cheung MC, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography. J Biol Chem 259:12201-12209, 1984
13. Johansson J, Carlson LA, Landou C, et al: High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Arterioscler Thromb 11:174-182, 1991
14. Barbaras R, Puchois P, Fruchart J-C, et al: Cholesterol efflux from cultured adipose cells is mediated by LpA-I particles but not by LpA-I:A-II particles. Biochem Biophys Res Commun 142:63-69, 1987
15. Olivecrona G, Olivecrona T: Triglyceride lipases and atherosclerosis. Curr Opin Lipidol 6:291-305, 1995
16. Tall AR: Plasma lipid transfer proteins. J Lipid Res 27:361-366, 1986
17. Windier E, Chao Y-S, Havel RJ: Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins. J Biol Chem 255:8303-8307, 1980
18. Kandoussi A, Cachera C, Parsy D, et al: Quantitative determination of different apolipoprotein B containing lipoproteins by an enzyme linked immuno-absorbent assay: ApoB with apoCIII and apoB with apoE. J Immunoassay 12:305-323, 1991
19. Parra HJ, Arveiler D, Evans AE, et al: A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease. The ECTIM Study. Arterioscler Thromb 12:701-707, 1992
20. Genest J Jr, Cohn JS: Clustering of cardiovascular risk factors: Targeting high-risk individuals. Am J Cardiol 76:8A-20A, 1995 (suppl)
21. Bruckert E, Giral P, Salloum J, et al: Carotid stenosis is a powerful predictor of a positive electrocardiogram in a large hyperlipidemic population. Atherosclerosis 92:105-114, 1992
22. Patsch JR, Prasad S, Gotto AM Jr, et al: High density lipoprotein 2: Relationship of the plasma levels of this lipoprotein species to its composition, the magnitude of postprandial lipemia, and to the actions of lipoprotein lipase and hepatic lipase. J Clin Invest 80:341-347, 1987
23. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-503, 1972
24. Chapman MJ, Goldstein S, Lagrange D, et al: A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. J Lipid Res 22:339-358, 1981
25. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275, 1951
26. Bouthillier D, Sing CF, Davignon J: Apolipoprotein E phenotyping with a single gel method: Application to the study of informative matings. J Lipid Res 24:1060-1069, 1983
27. Menzel HJ, Kladetzky R, Assmann G: One-step screening method for the polymorphism of apolipoprotein A-I, A-II and A-IV. J Lipid Res 23:915-923, 1982
28. Albers JJ, Tollefson JH, Chen CH, et al: Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 4:49-58, 1984
29. Mann CJ, Yen FT, Grant AM, et al: Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia. J Clin Invest 88:2059-2066, 1991
30. Nilsson-Ehle P, Ekman R: Rapid, simple and specific assays for lipoprotein lipase and hepatic lipase. Artery 3:194-209, 1977
31. Godfrey K: Comparing the means of several groups. N Engl J Med 313:1450-1456, 1985
32. Patsch JR, Prasad S, Gotto AM Jr, et al: Postprandial lipemia: A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest 74:2017-2023, 1984
33. Tall A, Sammett D, Granot E: Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia. J Clin Invest 77:1163-1172, 1986
34. Grundy SM, Vega GL: Fibric acids: Effects on lipids and lipoprotein metabolism. Am J Med 27:9-20, 1987
35. Johansson J, Nilsson-Ehle P, Carlson LA, et al: The association of lipoprotein and hepatic lipase activities with high density lipoprotein subclass levels in men with myocardial infarction at a young age. Atherosclerosis 86:111-122, 1991
36. Mown HO, Patsch W, Smith LC, et al: Different reactivities of high density lipoprotein2 subfractions with hepatic lipase. J Lipid Res 33:1269-1279, 1992
37. Mowri HO, Patsch JR, Ritsch A, et al: High density lipoproteins with differing apolipoproteins: Relationships to postprandial lipemia, cholesteryl ester transfer protein, and activities of lipoprotein lipase, hepatic lipase, and lecithin: cholesterol acyltransferase. J Lipid Res 35:291-300, 1994
38. Föger B, Patsch JR: Strategies and methods for the assessment of distributed postprandial lipid metabolism. Curr Opin Lipidol 4:428-433, 1992
39. Karpe F, Bard J-M, Steiner G, et al: HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. Arterioscler Thromb 13:11-22, 1993
40. Agnani G, Bard JM, Candelier L, et al: Interaction of LpB, LpB:E, LpB:CIII, and LpB:CIII:E lipoproteins with the low density lipoprotein receptor of HeLa cells. Arterioscler Thromb 11:1021-1029, 1991
41. Ginsberg HN, Le N-A, Goldberg IJ, et al: Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein CIII and AI: Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest 78:1287-1295, 1986
42. Clavey V, Lestavel-Delattre S, Copin C, et al: Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII and E. Arterioscler Thromb Vasc Biol 15:963-971, 1995
43. Blankenhorn DH, Alaupovic P, Wickham E, et al: Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts: Lipid and nonlipid factors. Circulation 81:470-476, 1990
44. Luc G, Fievet C, Arveiler D, et al: Apolipoproteins CIII and E in apoB- and non-apoB-containing lipoproteins in two populations at contrasting risk for myocardial infarction: The ECTIM Study. J Lipid Res 37:508-517, 1996